Substance use & recovery

Where the 90-Day Recommendation Comes From

Save

"Ninety days" is shorthand for a finding: treatment works better with time, and roughly three months is where outcomes start to hold. It is not a magic number, not a cure date, and not a cap. For medication-based treatment it can be far longer. Here is where the figure comes from, why it replaced the old 28-day model, and what it does and doesn't promise.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Where the number comes from

The 90-day figure is not one study or one committee vote. It is a summary judgment drawn from many trials of many treatment types, distilled into the government's research-based guide to addiction treatment. That guide states plainly that remaining in treatment for an adequate time is critical to effectiveness, and that participation for less than about 90 days is of limited or no value for many people 2.

The reasoning behind it is biological and behavioral. Substance use disorder changes the brain's response to stress and reward, and those changes do not reverse in the time it takes the body to clear a drug. Rebuilding routines, treating co-occurring conditions, and practicing new responses to triggers takes sustained repetition. The three-month mark is where the accumulated evidence shows enough of that work has happened to change the trajectory for a meaningful share of people 1.

Why 90 days and not 28

Many people carry a mental image of the "28-day rehab," and it is worth knowing that the number has nothing to do with clinical evidence. The classic month-long inpatient stay descends from the abstinence-based Minnesota Model developed at programs beginning in the late 1940s and 1950s — an influential historical lineage, but not a finding that 28 days is the right amount of time 3.

The 28-day stay is a historical and insurance artifact; the 90-day figure is an evidence-based one.

The 28-day length hardened partly because insurance benefits and program structures settled around it, not because outcomes peak at four weeks. When researchers actually measured duration against results, the picture that emerged pointed past 28 days. This is why the 90-day principle and the 28-day origin story are usually read together: one is where the number came from, the other is what the evidence later said. How long a specific person's rehab length of stay should be is its own, more individual question.

What 90 days does and doesn't mean

Ninety days is a threshold, not a prescription. It does not mean a person must spend 90 days as an inpatient — the time can be spread across levels of care, stepping down from residential to a day program to outpatient while the clock keeps running. It does not mean someone is cured at day 90, and it does not mean treatment should stop there. And it does not mean a shorter stay is worthless; for some people a briefer, well-matched course plus strong continuing care works.

What it does mean is that duration is a lever on outcomes, and cutting treatment short is one of the most common ways a plan fails 2. The right length is matched to the person's needs and progress, not to a fixed program length an admissions desk quotes. When a program markets a rigid "30-day" or "60-day" package as complete in itself, that is a business model talking, not the evidence.

For medication-based treatment, the clock is different

The 90-day principle describes a floor for episodes of behavioral treatment. For opioid use disorder treated with medication, the relevant timeframe is usually much longer, and often open-ended. Medications like buprenorphine work in part by keeping people in treatment: at adequate doses, buprenorphine retains patients far better than placebo, and retention is itself protective 5.

Staying on medication for months or years is the treatment working, not a failure to finish it.

Here the question is not "have you done your 90 days?" but "is this medication still helping you stay well?" Stopping it on a schedule, to hit an arbitrary end date, discards its main benefit and raises the risk of return to use and overdose. Understanding how medication-assisted treatment fits the duration question — that its horizon is measured differently from a residential stay — is essential to reading the 90-day figure correctly. It applies to courses of therapy, not to a decision about how long to stay on medication.

Why some people need considerably longer

Ninety days is a starting reference, and plenty of people need more time. A major reason is co-occurring conditions: substance use disorders and other mental illnesses frequently occur together, and the evidence favors treating both at the same time rather than one after the other 4. Untangling depression, trauma, or an anxiety disorder alongside a substance use disorder simply takes longer than treating either alone.

Severity, the substance involved, prior treatment history, and the stability of a person's home and support all push the number up or down. This is why the honest answer to "how long?" is never a single figure. Ninety days is the evidence-based reference point that replaced an arbitrary one; the individualized answer sits on top of it. For people worried about affording a longer course, publicly funded and state-funded rehab pathways exist and are covered separately.

Common questions

No. The 90 days refers to total time engaged in treatment, not time as an inpatient. That time can be spread across levels of care — for example, a few weeks residential, then a day program, then outpatient — with the clock continuing throughout. The principle is about sustained engagement, not about one long stay in a single setting.

The month-long inpatient stay descends from the abstinence-based Minnesota Model developed at treatment programs starting in the late 1940s and 1950s. It became standard partly because insurance benefits and program structures settled around it — not because research showed outcomes peak at four weeks. When duration was actually studied, the evidence pointed past 28 days.

Not necessarily. Some people do well with a shorter, well-matched course followed by strong continuing care. The concern is a program marketed as complete in itself with nothing after it. The evidence shows outcomes improve with adequate time, so a brief stay works best when it is one part of a longer plan rather than the whole of it.

Not in the same way. The 90-day figure describes episodes of behavioral treatment. Medications like buprenorphine or methadone for opioid use disorder are often continued for much longer, sometimes indefinitely, because staying on them is protective. Stopping medication to hit an arbitrary end date discards its main benefit and can raise overdose risk.

Ninety days is a floor, not a ceiling. Co-occurring mental-health conditions, greater severity, the substance involved, and an unstable home all commonly call for longer treatment. Since substance use disorders and other mental illnesses often occur together and are best treated at the same time, that combined work frequently takes more than three months.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

If things feel heavy, a person is available anytime — call or text 988.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When treatment length is not the urgent question

  • An opioid overdose after any break in use — slow or absent breathing, blue or gray lips, or a person who cannot be woken — tolerance drops during abstinence and a former amount can be fatal
  • A withdrawal seizure, or confusion, fever, and a racing heart during alcohol or sedative withdrawal
  • Thoughts of suicide, especially in the low period after leaving a program
  • A program pressuring a decision with a fixed 'day' package and no plan for what comes after

Call 911 for a suspected overdose or a withdrawal seizure, and give naloxone if opioids may be involved. For thoughts of suicide, call or text 988. SAMHSA's National Helpline, 1-800-662-HELP, provides free, confidential treatment referrals 24/7.

This article is general health information about treatment-duration research, not medical advice. How long a specific person should stay in treatment depends on their diagnosis, severity, co-occurring conditions, and progress, and should be decided with a licensed clinician.

References

  1. 1.National Institute on Drug Abuse (2018). Principles of Drug Addiction Treatment: A Research-Based Guide (Third Edition) — Preface. National Institute on Drug Abuse (NIDA), NIH. linkUsed for the claim that good outcomes depend on adequate treatment duration, that individuals typically need at least three months to significantly reduce or stop use, and that longer durations produce better outcomes.
  2. 2.National Institute on Drug Abuse (2018). Principles of Drug Addiction Treatment: A Research-Based Guide (Third Edition). National Institute on Drug Abuse (NIDA), NIH. linkUsed for the claim that remaining in treatment for an adequate time (generally 90+ days for residential/outpatient) is critical to effectiveness and that cutting treatment short is a common way plans fail.
  3. 3.Hazelden Betty Ford Foundation (2020). The Minnesota Model. Hazelden Betty Ford Foundation. linkUsed for the historical claim that the classic ~28-day inpatient stay descends from the abstinence-based Minnesota Model developed beginning in the late 1940s and 1950s — an origin story, not evidence that 28 days is clinically optimal.
  4. 4.National Institute on Drug Abuse (2024). Co-Occurring Disorders and Health Conditions. National Institute on Drug Abuse (NIDA), NIH. linkUsed for the claim that substance use disorders and other mental illnesses frequently co-occur and are best treated at the same time, which is one reason some people need longer than 90 days.
  5. 5.Mattick RP, Breen C, Kimber J, Davoli M (2014). Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD002207.pub4Used for the claim that at adequate doses buprenorphine retains patients in treatment far better than placebo, so medication-based treatment is measured on a longer, often open-ended horizon rather than a 90-day episode.

5 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy